IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells

Dendritic cell (DC) tumor vaccines exert their antitumor effects through the induction of effector T cells. We recently identified Tc9 cells as a new potent antitumor effector T cell subset. However, approaches to direct DCs to preferably prime antitumor Tc9 cells should be further exploited. Here,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cell Mol Immunol
Autores principales: Liu, Ning, Jiang, Yuxue, Chen, Jintong, Nan, He, Zhao, Yinghua, Chu, Xiao, Wang, Alison, Wang, Dongjiao, Qin, Tianxue, Gao, Sujun, Yi, Qing, Yue, Ying, Wang, Siqing
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804534/
https://ncbi.nlm.nih.gov/pubmed/30275536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-018-0166-0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares